1. Introduction {#sec1}
===============

Traditional Chinese Medicine (TCM) is getting more attention all over the world due to its exact clinical practice, especially prescription application, which comprehensively highlights the quintessence of the theory of traditional Chinese medical science.*Da Chuan Xiong Fang* (DCXF), a well-known and extensively used TCM decoction for the treatment of migraine, first appeared in*Xuan Ming Lun Fang,* a famous formula book written by Wansu Liu who lived in Jin Dynasty (1115--1234). It is composed of two herbs, namely, Chuanxiong (*Chuanxiong rhizoma*) and Tianma (*Gastrodiae rhizoma*), with a crude weight ratio of 4 : 1. Eight dosage forms of DCXF such as capsule, tablet, dripping-pill, honeyed pill, oral liquid, and granule, have been authorized to Chinese market. Tianshu Capsule (TSC), as a representative of DCXF preparations, is widely used in clinics for treating the blood stasis type of headache and migraine \[[@B1], [@B2]\].

Phytochemical and pharmacological investigations showed that phenols, organic acids, phthalides, and nitrogen-containing compounds were the major active ingredients of DCXF \[[@B3]\]. Several qualitative analyses have been reported concerning main types of constituents in DCXF \[[@B4]--[@B7]\]. One study described the identification of 17 different constituents in the 50% EtOH extract of DCXF by LC-Q-TOF/MS, containing gastrodin, parishin C, ferulic acid, guanosine, adenosine, palmitic acid, and 11 phthalide compounds \[[@B4]\]. Another similar study identified 3 compounds of Chuanxiong (ferulic acid, senkyunolide I, and senkyunolide H) and 8 constituents of Tianma (gastrodin, s-(4-hydroxybenzyl)-glutathione, parishin, parishin B, parishin C, p-hydroxybenzaldehyde, etc.) by using the HPLC-DAD-MS^n^ coupling technique, respectively \[[@B5]\]. Continuous reports from the second research group confirmed that 10 different compounds, including 6 original substances of Chuanxiong and 4 original ones of Tianma, were detected in the rat plasma after the gavage of DCXF active components \[[@B6], [@B7]\]. However, all these investigations mentioned above were carried out based on the samples of the 50% EtOH extract of the mixture of both herbs (4 : 1) or active components of single crude herb. No systematic reports could be available involving the chemical profiling of the commercial finished products derived from DCXF. TSC was produced from both crude herbs by employing the various pharmaceutical engineering technologies and the complex manufacturing processes such as extraction, concentration, and preparation. The accumulating studies showed that decocting could induce chemical changes of medicinal herbs or combinatorial formula \[[@B8]\]. It is well-known that ferulic acid and some of the phthalides such as*Z*-ligustilide and dimeric phthalide are unstable at high temperature \[[@B9], [@B10]\]. Therefore, during the preparation of TSC, these thermolabile components may undertake chemical transformation, consequently leading to the difference of chemical compositions of finished products with DCXF decoction. Understanding the chemical profiles of TSC samples would be helpful in selecting suitable chemical markers for the quality control and pharmacokinetic study. In this work, a combination of HPLC, LC-DAD-MS^n^, and LC-DAD-ESI-IT-TOF/MS analyses was employed to find out and identify the common components in various batches of commercial TSC samples. The contribution of the characteristic peaks from individual herb to the whole chemical profiling of TSC was also discussed. A total of 38 constituents were identified or tentatively characterized, among which the water-soluble compounds with higher polarity from*Gastrodiae rhizoma* are detected in TSC samples for the first time.

2. Materials and Methods {#sec2}
========================

2.1. Materials and Reagents {#sec2.1}
---------------------------

Five batches of Tianshu Capsules and related crude herbal materials (*Chuanxiong rhizoma and Gastrodiae rhizoma*) were provided by*Kanion Pharmaceutical*(Lianyungang, China). The reference substances of gastrodin (Lot. 110807-200205), 5-hydroxymethyl-2-furfural (5-HMF, Lot. 111626-201007), ferulic acid (Lot. 0773-9607), and*Z*-ligustilide (Lot. 111737-201102) were purchased from the National Institutes for Food and Drug Control (Beijing, China). Parishin B (174972-79-3), parishin C (174972-80-6), and parishin (62499-28-9) were from the collection of Dr. Li Wang, Dalian Institute of Chemical Physics, Chinese Academy of Sciences (Dalian, China). The purity for each of these compounds was over 98% by HPLC assay and their structures were shown in [Figure 1](#fig1){ref-type="fig"}. HPLC grade methanol (Fisher, Fair Lawn, NJ, USA) and ultrapure water were used for HPLC analyses. All other chemical reagents were of analytical grade from Beijing Chemical Corporation (Beijing, China).

2.2. Sample Preparation {#sec2.2}
-----------------------

### 2.2.1. TSC Sample {#sec2.2.1}

1.0 g of pulverized contents of TSC samples was extracted with aqueous methanol (MeOH-H~2~O, 1 : 1, 25 mL) by ultrasonication (250 w, 40 kHz) for 30 min at room temperature, and the extract was then centrifuged for 10 min at 14800 rpm. A volume of 10 *μ*L of the supernatant was used for HPLC and LC-DAD-MS^n^ analysis.

### 2.2.2. Extraction of Chuanxiong Rhizoma, Gastrodiae Rhizoma, and DCXF {#sec2.2.2}

The ethanolic and aqueous extracts of individual herb (*Chuanxiong rhizoma* and*Gastrodiae rhizoma*) and the mixture of both herbs (w/w, 4 : 1, DCXF) were prepared according to the manufacturing processes of TSC (Figure S1 in the Supplementary Material available online at <http://dx.doi.org/10.1155/2014/580745>) described in the current Chinese pharmacopoeia. The ethanolic and aqueous extracts were diluted with aqueous methanol (MeOH-H~2~O, 1 : 1) to the concentration of 0.05 g·mL^−1^ and then centrifuged for 10 min at 14800 rpm. Each of the supernatants was used for HPLC and LC-MS analyses.

### 2.2.3. Reference Solution {#sec2.2.3}

Stock solutions with a concentration of about 0.010 mg·mL^−1^ were prepared by dissolving an accurately weighed amount of each reference substance in aqueous methanol (MeOH-H~2~O, 1 : 1). The mixture of 7 reference solutions was prepared from the stock solutions.

2.3. Qualitative HPLC Analyses of 5 Batches of TSC Samples {#sec2.3}
----------------------------------------------------------

The analyses were performed on a Shimadzu HPLC system (Shimadzu, Japan) equipped with a LC-20AT binary pump, a DGU-20A5 degasser, a SIL-20AC autosampler, a CTO-20AC column oven, and a SPD-M20A photodiode array detector. The samples were separated on a Phenomenex Luna C~18~ column (5 *μ*m, 4.6 × 250 mm). The mobile phase consisted of methanol (A) and water containing 0.1% formic acid (B) using a gradient program as follows: 0 min, 15% A; 5 min, 15% A; 55 min, 95% A; 60 min, 95% A. The flow rate was 1.0 mL·min^−1^ and the column temperature was set at 30°C. The PDA detector recorded UV spectra in the range from 190 nm to 400 nm and HPLC chromatogram was monitored at 276 nm.

2.4. Comparison of Typical TSC Sample and Its Related Crude Herbal Materials as Well as DCXF by HPLC and LC-MS {#sec2.4}
--------------------------------------------------------------------------------------------------------------

TSC sample and its related crude herbal material,*Chuanxiong rhizoma*and*Gastrodiae rhizoma*as well as DXCF, were analyzed under the same chromatographic conditions by HPLC and LC-MS to find the contribution of individual herb to the whole chemical profile of TSC sample. The HPLC system was the same as those in [Section 2.3](#sec2.3){ref-type="sec"}. LC-MS analyses were performed using an Agilent 6130 Quadrupole LC-MS (Agilent, Waldbronn, Germany) connected to an Agilent 1200 HPLC system (Agilent, Waldbronn, Germany). The parameters for MS analysis in the positive and negative ion mode were as follows: nebulizer, 35 psi; ionization voltage, 3500 V; dry temperature, 350°C; flow rate of carrier gas, 9.0 L·min^−1^. Full-scan mass spectra were acquired in the range of 100--800*m/z*.

2.5. LC-DAD-ESI-IT-MS^n^ Analysis of Typical TSC Sample {#sec2.5}
-------------------------------------------------------

To comprehensively identify the chemical constituents in TSC sample by the fragmentation rules, a LC-DAD-ESI-IT-MS^n^ experiment was performed using an Agilent 6320 ion-trap spectrometer (Agilent, Waldbronn, Germany) connected to an Agilent 1200 HPLC system (Agilent, Waldbronn, Germany). The HPLC conditions were the same as those described in [Section 2.3](#sec2.3){ref-type="sec"}. The LC effluent was introduced into an electrospray ionization source after a postcolumn split ratio of 2 : 1. The parameters for MS analysis in the positive ion mode were as follows: nebulizer, 45 psi; ionization voltage, 4000 V; dry temperature, 350°C; flow rate of carrier gas, 12.0 L·min^−1^. Full-scan mass spectra were acquired in the range of 100--800*m/z*. The optimized parameters for MS/MS analysis were as follows: collision energy, 1.5 V; nitrogen was used as the collision gas. MS^n^ spectra of pure substances were obtained using the same parameters as mentioned above.

2.6. LC-DAD-ESI-IT-TOF/MS of Analysis of Typical TSC Sample {#sec2.6}
-----------------------------------------------------------

To confirm the elemental composition of precursor ions and their fragments with high-accurate mass, a LC-ESI-IT-TOF/MS experiment was performed on a Shimadzu LC-MS-IT-TOF instrument equipped with a Shimadzu UFLCXR HPLC system (Shimadzu, Kyoto, Japan). The HPLC system consisted of a CBM-20A controller, two LC-20AD binary pumps, an SPD-M20A diode array detector, an SIL-20AC autosampler, a CTO-20A column oven, and a DGU-20A3 degasser. The HPLC conditions were the same as those for HPLC-DAD-ESI-MS^n^ analysis. The LC effluent was directed into the ESI source as a rough split ratio of 3 : 1. The optimized MS conditions were as follows: positive and negative ion mode; electrospray voltage, +4.5 kV/−3.5 kV; detector voltage, 1.65 kV; curved desolvation line (CDL) temperature, 200°C; heat block temperature, 200°C; nebulizing gas (N~2~), 1.5 L·min^−1^; drying gas (N~2~), 10 L·min^−1^; scan range,*m/z* 100--1100 for MS^1^, 100--800 for MS^2^, and 100--500 for MS^3^. The ultrahigh purity argon was used as the collision gas for collision-induced dissociation (CID) experiments, and the collision energy was set at 50% for MS^2^ and MS^3^; ion accumulated time was 30 ms. The MS^n^ data were collected in an automatic mode and the software could automatically select precursor ions for MS^n^ analysis according to criteria settings. Accurate mass determination was corrected using the external standard method. The data acquisition and analysis were performed by LC-MS Solution Version 3.6 software (Shimadzu, Kyoto, Japan).

3. Results and Discussion {#sec3}
=========================

3.1. Qualitative Analyses of TSC and Its Related Crude Herbal Materials by HPLC and LC-MS {#sec3.1}
-----------------------------------------------------------------------------------------

Under the HPLC conditions as described in the current Chinese Pharmacopoeia \[[@B1]\], 5 batches of TSC samples, together with the reference compounds, were examined and their HPLC chromatograms were shown in Figure S2. High similarity in the number, type, and amount of chemical constituents was observed in the HPLC profiles of different batches of TSC samples. General chromatographic profile was obtained by Similarity Evaluation System for Chromatographic Fingerprint of Traditional Chinese Medicine software and characteristic peaks were found in the HPLC profile of each individual sample.

In order to identify the origin of these characteristic peaks from individual herbs, a comparative study was carried out by using various extracts of herbs and TSC samples. Accordingly, the possible individual contribution from the corresponding herbs to the general chromatographic profile was found. Compared with the HPLC profiles of the ethanolic and aqueous extracts of*Chuanxiong rhizoma and Gastrodiae rhizome* (Figure S3), 29 of 38 peaks occurring in HPLC profile of TSC sample were contributed by*Chuanxiong rhizoma* and other 9 peaks came from G*astrodiae rhizome* (Figures S4 \~ S10). In addition to the comparison of retention time and on-line UV spectra with those of reference compounds gastrodin, 5-HMF, parishin B, parishin C, parishin, ferulic acid, and*Z*-ligustilide, the precursor ions obtained by the positive and negative LC-MS ([Figure 2](#fig2){ref-type="fig"}) such as \[M+H\]^+^, \[M+NH~4~\]^+^, \[M+Na\]^+^, and \[M-H\]^−^ further confirmed the contribution of the characteristic peaks from individual herbs to the chromatographic profile of TSC sample ([Table 1](#tab1){ref-type="table"}).

3.2. Identification of Chemical Constituents in TSC by LC-DAD-EST-IT-MS^n^ and LC-DAD-ESI-IT-TOF/MS {#sec3.2}
---------------------------------------------------------------------------------------------------

The combination of LC-DAD-ESI-IT-MS^n^ and LC-DAD-ESI-IT-TOF/MS experiments was employed for the identification of chemical constituents in TSC sample, and, as a result, a total of 38 compounds was identified or tentatively characterized. The structures of the identified compounds are shown in [Figure 1](#fig1){ref-type="fig"} and their chromatographic and mass spectrometric data are shown in Tables [2](#tab2){ref-type="table"} and [3](#tab3){ref-type="table"}. The total ion chromatograms (TICs) of TSC sample are shown in Figures S11 and S12, respectively. Among the identified constituents, 7 compounds (**2**,**3**,**5**,**6**,**7**,**9,** and**26**) were unambiguously identified as gastrodin, 5-HMF, parishin B, parishin C, parishin, ferulic acid, and*Z*-ligustilide based on the direct comparison of their retention times, UV spectra, and mass spectra with those of the authentic compounds. Furthermore, 31 compounds were tentatively characterized according to their UV spectra, empirical molecular formula, and mass fragmentation pathways as well as their eluted sequence from ODS column reported in the literature \[[@B11]--[@B14]\] and acquired in the present experiments.

### 3.2.1. Fragmentation Characteristic of Reference Compounds {#sec3.2.1}

In the present HPLC and MS conditions, characteristic MS adduct ions were observed for phenolic glycosides, organic acid, and phthalide derivatives. Phenolic glycosides and organic acids could be well-detected in positive and negative ionization mode and adduct ions such as \[M+H\]^+^, \[M+NH~4~\]^+^, \[M+Na\]^+^, and \[2M+Na\]^+^ or \[M-H\]^−^ and \[M+HCOO\]^−^ were found, whereas phthalides were only detected in positive mode and mainly showed the abundant \[M+H\]^+^, \[M+Na\]^+^, and \[2M+Na\]^+^ ions. The fragmentation characteristic of reference compounds was similar as those described in the literature \[[@B11], [@B14], [@B15]\]. For example, gastrodin, the glucoside of*p*-hydroxybenzyl alcohol, mainly showed characteristic product ions at*m/z*123 and 161 corresponding to the elimination of a molecule of glucose and a molecule of*p*-hydroxybenzyl alcohol from*m/z* 285 \[M-H\]^−^, respectively. Parishin B and C, the gastrodin derivatives with citric acid, mainly indicated the fragmentation of the ester glucoside bond and the neutral loss of gastrodin residue (268 Da) corresponding to the ion at*m/z* 459. The ions at*m/z*441, 423, 397, and 379 were also observed, which were related to elimination of H~2~O and CO~2~ from the tertiary alcoholic hydroxyl group and the free carboxylic groups produced by breaking of the ester glucoside bond. Phthalides mainly displayed two pathways: side-chain cleavage with loss of alkenes and ring-opening followed by elimination of H~2~O and CO. These series of characteristic ion rules would be beneficial to elucidate the chemical constituents in TSC sample.

### 3.2.2. Identification of Phenolics Derivatives in TSC Sample {#sec3.2.2}

Compounds**1** and**2** gave the same on-line UV spectrum which is in accordance with that of gastrodin. The structure of**2** was identified as gastrodin based on the comparison of retention time, UV spectrum, and characteristic fragment ions with those of authentic compound as well as accurate molecular weight. The molecular weight of**1** was deduced as 448 from the sodium adduct ion at*m/z* 471 \[M+Na\]^+^ detected in positive mode and deprotonated molecular ion at*m/z* 447 \[M-H\]^−^ in negative mode, respectively. A prominent neutral loss of 162 Da, corresponding to the loss of hexose, and disaccharide residue ions at*m/z* 323 were observed in MS^2^ of the \[M-H\]^−^ ion at*m/z* 447. The loss of 124 Da was assigned to*p*-hydroxybenzyl alcohol just like the characteristic loss of gastrodin. Therefore, compound**1** was identified as elatoside, namely, 6′-(*p*-hydroxybenzyl methyl)-gastrabiose, which was previously isolated from the rhizome of*G*.*elata*\[[@B16]\].

Compounds**4**,**5**,**6,** and**7** gave the adduct ions \[M+Na\]^+^ and \[M+NH~4~\]^+^ in positive LC-MS and \[M-H\]^−^ in negative LC-MS experiments as well as UV spectra, which were similar to those of gastrodin derivatives. Compounds**5** and**6** had the same \[M-H\]^−^ ions at*m/z* 727, which produced the prominent fragment ion at*m/z* 459 in the MS^2^, due to loss of gastrodin residue (268 Da) as well as other ions at*m/z*441, 423, 397, and 379. Combining with retention time and addition of reference substances,**5** and**6** were identified as parishin B and C. Similarly, compound**4**was assigned to parishin E or its positional isomer parishin G with identical molecular mass of 460 \[[@B17]\]. Compound**7** had the molecular mass of 996 and exhibited consecutive loss of gastrodin residue (268 Da), and, therefore, it was identified as parishin, a conjugate of one citric acid and three gastrodins.

### 3.2.3. Identification of Phthalide Derivatives in TSC Sample {#sec3.2.3}

The molecular formula of compound**8**, detected from individual herb*Chuanxiong rhizoma*, was calculated as C~12~H~18~O~5~ by \[M+H\]^+^ ion at*m/z* 243.1220 and \[M-H\]^−^ ion at*m/z* 241.1090 in its LC-IT-TOF/MS experiment. It had the same molecular weight of 242 as those of known compounds, senkyunolide L and 3-butyl-3,6,7-trihydroxy-4,5,6,7-tetrahydrophthalide, present in*Chuanxiong rhizoma*; however, compound**8** could not be senkyunolide L (C~12~H~15~ClO~3~) because both had the different element composition \[[@B18]\]. The fragmentation ion of**8** at*m/z* 197.1142, which was derived from a retro-Diels-Alder cleavage of the \[M-H-H~2~O\]^−^ ion at*m/z* 223.0885, suggested that the structure of**8** was proposed as 3-butyl-3,6,7-trihydroxy-4,5,6,7-tetrahydrophthalide.

Compound**10** displayed \[M+H\]^+^ ion at*m/z* 227.1259, suggesting the molecular formula of C~12~H~18~O~4~. The fragment ions at*m/z* 209 and 191 in the MS^2^, indicating consecutive loss of H~2~O, supported that**10** was a dihydroxylated derivative of ligustilide. UV and MS data of**10** were in accordance with those of senkyunolide J and senkyunolide N, but the stereochemistry information of two hydroxy groups could not be provided. Thus,**10** was tentatively assigned as one of senkyunolide J and senkyunolide N. Compounds**11** and**12** gave the same \[M-H\]^−^ ions at*m/z* 224 and their molecular formula was established as C~12~H~18~O~4~ according to the \[M+H\]^+^ ion at*m/z* 225.1105. However, both constituents had different fragmentation rules. The MS^2^ of**11** displayed the fragment ions at*m/z* 207, 189 and the characteristic ion at*m/z* 165, which were similar to those of 4,5-dihydro-3,1′-dihydroxy-3-butylphthalide \[[@B15]\], whereas**12** showed elimination of two H~2~O followed by side-chain cleavage. Therefore,**11** was deduced as 4,5-dihydro-3,1′-dihydroxy-3-butylphthalide and**12** could be one of senkyunolide I and senkyunolide H \[[@B14], [@B15]\].

Compounds**13**,**17,** and**19** have the same molecular formula of C~12~H~14~O~3~ and were tentatively characterized as 4-hydroxy-3-butylphthalide,*Z*-6,7-epoxyligustilide, and senkyunolide F. Compared with monohydroxy phthalide derivatives**13** and**19**, the instable structure of**17** resulted in the ion at*m/z* 189 as base peak observed in MS^1^, suggesting loss of H~2~O from the \[M-H\]^−^ ion at*m/z* 207. Senkyunolide A**20** and*Z*-ligustilide**26** as main constituents were identified and butylphthalide**21**, senkyunolide C**22**, senkyunolide E**23**,*E*-ligustilide**24,** and 3-butylidenephthalide**28** were characterized as minor constituents. For the compounds**20**,**21**,**24,** and**26**, the neutral loss of CO (28 Da) and side-chain cleavage (56 Da) from \[M+H-H~2~O\]^+^ were the common fragmentation rules.

Compound**16** (C~12~H~14~O~3~) was tentatively proposed to 4,7-dihydroxy-3-butylidenephthalide or senkyunolide D. Compound**18** was assigned as senkyunolide K or senkyunolide G. These compounds and their isomers could not be differentiated by available MS data.

Five dimeric ligustilides**29**,**31**,**32**,**34,** and**35**, which produced the protonated ion \[M+H\]^+^ at*m/z* 381, were detected in extracted ion chromatograms. They showed the base peak at*m/z* 403 \[M+Na\]^+^ in MS^1^ and the fragment ion at*m/z* 191 \[M+H-190\]^+^ as base peak in MS^2^ by the loss of a RDA fragment (145 Da) followed by the loss of H~2~O and HCOOH (46 Da). Comprehensively considering the information described in the literature \[[@B14]\], they were tentatively identified as riligustilide, 3′,6,8′,3a-biligustilide, tokinolide B, levistolide A, and senkyunolide O, respectively. Three compounds, indicating the protonated ion \[M+H\]^+^ at*m/z*383, were detected in extracted ion chromatograms; however, only senkyunolide P was previously reported in*Chuanxiong Rhizoma*. Thus, compound**30** was tentatively characterized as senkyunolide P and the other compounds (**33** and**38**) were still indefinite based on the available information.

In the modernization of TCM, chemical profiling is always the first task. It is of importance for development of the suitable quality standard and control strategy, study of pharmacokinetics, and interpretation of therapeutic character of TCM \[[@B19], [@B20]\]. As a marketed product in China, the quality control system of TSC is still to be improved and its pharmacokinetics and action mechanism are not completely clear. Usually, gastrodin, ferulic acid, and 6,7-dihydroxyligustilide are selected as marker compounds for the quality control or the pharmacokinetic study of Tianshu Capsule \[[@B1], [@B21], [@B22]\]. The present investigation provides more chemical information for the selection of the marker compounds and the improvement of quality control. It also tells the pharmacokinetic scientists and ethnopharmacologists which compounds in TSC samples are worth further evaluation. In addition to gastrodin and ferulic acid, more efforts should be made to the group of phthalide derivatives such as major constituents, senkyunolide I/H**12**, 4-hydroxy-3-butylphthalide**13**, senkyunolide A**20,** and*Z*-ligustilide**26** as well as their dimers. Additionally, it is worth noting that 5-HMF**3**, a potent toxic compound, was found as main peak in the chemical profile of TSC samples. This compound originated from the crude material*Gastrodiae rhizoma*and its content in TSC samples was up to 2.67 mg·g^−1^ \[[@B23]\]. If it is necessary to develop its limit standard in TSC product or not, more study are expected. Also, ligustrazine is not detected in TSC sample, even in the extracted ion chromatogram, which could result from its very low amount in crude herbal material (about 0.01\~0.02%), although, actually, it is often considered as one of active components in*Chuanxiong rhizoma*.

4. Conclusions {#sec4}
==============

In this study, HPLC analysis was employed to find out the common chromatographic peak in various batches of TSC samples. The contribution of the characteristic peaks from individual herbs to the whole chromatographic profile was discussed based on comparative HPLC and LC-MS analyses. A total of 38 constituents were identified based on the comparison of retention time and UV spectra with authentic compounds as well as by summarized MS fragmentation rules and matching empirical molecular formula with those of published components. The present investigation provided the good basis for monitoring the manufacturing processes and improving quality control of TSC products.

Supplementary Material {#supplementary-material-sec}
======================

###### 

Figure S1 The pharmaceutical manufacture process of TSC described in current Chinese Pharmacopoeia

Figure S2. HPLC of 5 batches of TSC samples at 276 nm

Figure S3. HPLC of reference solution (RS) and TSC sample. A. RS at 276 nm, B. RS at 221 nm, C. TSC sample at 276 nm, D. TSC sample at 221 nm.

Figure S4. HPLC of ethanolic (e) or aqueous (a) extracts of *Da Chuanxiong Fang* (D.), *chuanxiong rhizoma* (C.) and *gastrodiae rhizoma* (G.) at 276 nm.

Figure S5. HPLC and TIC of ethanolic extract of *Da Chuanxiong Fang*. A. HPLC (276 nm), B. (+) TIC, C. (-) TIC.

Figure S6. HPLC and TIC of aqueous extract of *Da Chuanxiong Fang*. A. HPLC (276 nm), B. (+) TIC, C. (-) TIC.
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![The structures of the identified compounds in TSC sample.](ECAM2014-580745.001){#fig1}

![HPLC and TIC of typical TSC sample obtained using an Agilent 6130 Quadrupole LC-MS connected to an Agilent 1200 HPLC system. (a) HPLC (276 nm), (b) (+) TIC, and (c) (−) TIC.](ECAM2014-580745.002){#fig2}

###### 

Retention time (*t* ~*R*~), UV, and LC-MS data of the identified compounds in Tianshu Capsule and related crude materials.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Number   *t* ~*R*~/min   UV *λ* ~max⁡~/nm   MW    \[M − H\]^−^   \[M + H\]^+^   \[M + NH~4~\]^+^   \[M + Na\]^+^   \[2M + Na\]^+^   \[M + HCOO\]^−^   Tianma   Chuanxiong   Identified compounds
  -------- --------------- ------------------ ----- -------------- -------------- ------------------ --------------- ---------------- ----------------- -------- ------------ -------------------------------------
  **2**    5.403           221, 276           286                                 304                                                 331               \+       −            Gastrodin

  **3**    7.736           230, 283           126                  127            144                149                                                \+       −            5-HMF

  **4**    15.579          225                460   459                           478                483                                                \+       −            Parishin E/G

  **5**    20.691          221, 272           728   727                           746                751                                                \+       −            Parishin B

  **6**    22.220          221, 274           728   727                           746                751                                                \+       −            Parishin C

  **8**    25.080          218                242   241            243                               265             507                                −        \+           3-Butyl-3,6,7-trihydroxy-4,5,6,7\
                                                                                                                                                                              -tetrahydrophthalide

  **9**    25.567          220, 236, 323      194   193            195                               217                                                \+       \+           ferulic acid

  **10**   27.529          220, 330           226                  227                               249             475                                −        \+           Senkyunolide J/N

  **11**   30.667          280                224                  225                               247             471                                −        \+           4,5-Dihydro-3,1′-dihydroxy-3\
                                                                                                                                                                              -butylphthalide

  **13**   32.436          275                206   205            207                                                                                  −        \+           4-hydroxyl-3-butylphthalide

  **14**   34.299          325                396                  397                                                                                  \+       \+           unidentified

  **16**   38.635          220, 270           222   221            223                               245                                                −        \+           Senkyunolide D or\
                                                                                                                                                                              4,7-dihydroxy-3-butylidenephthalide

  **17**   39.502          230, 310           206   205            207                               229                              435               −        \+           *Z*-6,7-Epoxyligustilide

  **18**   39.898          280                208   207            209                               231                              439               −        \+           Senkyunolide K/G

  **19**   41.465          220                206   205            207                               229                              435               −        \+           Senkyunolide F

  **20**   42.332          220, 240, 325      192                  193                               215             407                                \+       \+           Senkyunolide A

  **21**   42.956          226, 280           190                  191            208                213             403                                −        \+           Butylphthalide

  **22**   43.717          218, 270           204   203            205                               227             431              249               −        \+           Senkyunolide C

  **23**   44.147          210, 285, 330      204   203            205                               227             431              249               −        \+           Senkyunolide E

  **24**   44.949          220, 270, 330      194                  195                               217             411                                −        \+           Cnidilide

  **26**   45.831          205, 280, 328      190                  191                               213             403                                −        \+           Ligustilide

  **27**   46.394          220                194                  195                               217             411                                −        \+           Neocnidilide

  **28**   46.653          210, 275, 330      188                  189            206                211             399                                −        \+           3-Butylidenephthalide

  **29**   47.231          225, 280, 310      380                  381            398                403                                                −        \+           Riligustilide

  **30**   50.042          276                382                  383            399                405                                                −        \+           Senkyunolide P

  **31**   50.476          220, 280           380                  381            398                403                                                −        \+           3′,6,8′,3a-Biligustilide

  **32**   50.970          220, 280           380                  381            398                403                                                −        \+           Tokinolide B

  **33**   51.065          230, 279           382                  383            400                405                                                −        \+           Unidentified

  **34**   51.962          220, 275           380                  381                               403                                                −        \+           Levistolide A

  **35**   52.267          220, 285           380                  381                                                                                  −        \+           3′*Z*-3,3′a,8,6′a-Biligustilide

  **36**   52.693          220, 280           278                  279            301                579                                                −        \+           Senkyunolide M

  **37**   53.134          220, 280           278                  279            301                579                                                −        \+           Senkyunolide Q

  **38**   53.852          225, 278           382                  383            400                405             383                                −        \+           Unidentified
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Retention time (*t* ~*R*~), UV, and MS^n^ data obtained by LC-DAD-ESI-IT-MS^n^ of the identified compounds in Tianshu Capsule.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Number   *t* ~*R*~/min   Identified compounds             UV *λ* ~max⁡~/nm   \[M + Na\]^+^   \[M + H\]^+^   \[2M + Na\]^+^   Main product ions                                         \[M − H\]^−^   \[M + HCOO\]^−^   Main product ions
  -------- --------------- -------------------------------- ------------------ --------------- -------------- ---------------- --------------------------------------------------------- -------------- ----------------- ---------------------------------
  **1**    6.3             Gastrodin glucose (448)          221, 276           471                                                                                                       447            493               323\[M -- H-C~7~H~8~O~2~\]^−^,\
                                                                                                                                                                                                                          285\[M -- H-glc\]^−^, 179

  **2**    6.3             Gastrodin (286)                  220, 269           309                                             185\[M + Na-C~7~H~8~O~2~\]^+^                             285            331               161\[M -- H-C~7~H~8~O~2~\]^−^,\
                                                                                                                                                                                                                          123\[M -- H-glc\]^−^

  **3**    8.1             5-HMF (126)                      230, 283                           127                             109\[M + H-H~2~O\]^+^                                     125                               

  **5**    20.3            Parishin B (728)                 221, 272           751                                             483\[M + Na-268\]^+^, 215\[483-268\]^+^                   727                              459, 441, 423, 397, 379, 217

  **6**    21.8            Parishin C (728)                 221, 274           751                                             483\[M + Na-268\]^+^, 215\[483-268\]^+^                   727                              459, 441, 423, 397, 379, 217

  **7**    23.4            Parishin (996)                   221, 271                                                                                                                     995                              727\[M -- H-268\]^−^

  **9**    26.0            Ferulic acid (194)               220, 236, 323                      195                             177\[M + H-H~2~O\]^+^,\                                                                     
                                                                                                                               145\[177-CH~3~OH\]^+^                                                                      

  **10**   27.4            Senkyunolide J/N (226)           220, 330           249                            475              209\[M + H-H~2~O\]^+^,\                                                                     
                                                                                                                               191\[M + H-2H~2~O\]^+^,\                                                                   
                                                                                                                               163\[M + H-2H~2~O-28\]^+^                                                                  

  **11**   30.4            4,5-Dihydro-3,1′-dihydroxy\      280                247                                             207\[M + H-H~2~O\]^+^, 189\[M + H-2H~2~O\]^+^, 165, 121                                     
                           -3-butylphthalide (224)                                                                                                                                                                        

  **12**   31.6            Senkyunolide I/H (224)           276                247                                             207\[M + H-H~2~O\]^+^, 189\[M + H-2H~2~O\]^+^,\                                             
                                                                                                                               161\[189-H~2~O\]^+^, 133\[189-56\]^+^                                                      

  **15**   37.0            Unidentified (316)               230, 276, 280      339             317                             299\[M + H-H~2~O\]^+^, 281\[M + H-2H~2~O\]^+^,\           315                               
                                                                                                                               271\[M + H-H~2~O-28\]^+^, 243                                                              

  **17**   37.8            *Z*-6,7-Epoxyligustilide (206)   230                229                            413              189\[M + Na-H~2~O\]^+^, 171\[189-H~2~O\]^+^                                                 

  **18**   38.1            Senkyunolide K/G (208)           233, 280           231                            439              191\[M + H-H~2~O\]^+^, 173\[191 − H~2~O\]^+^,\                                              
                                                                                                                               149\[191-42\]^+^, 135\[191-56\]^+^                                                         

  **20**   40.2            Senkyunolide A (192)             280                215             193            407              175\[M + H-H~2~O\]^+^, 147, 119, 105                                                        

  **21**   40.7            Butylphthalide (190)             232, 275           213             191            403              173\[M + H-H~2~O\]^+^, 145, 117                                                             

  **24**   42.6            Cnidilide (194)                  238, 279, 327      217                                                                                                                                         

  **25**   43.3            *E*-Ligustilide (190)            281, 327           213             191            403              173\[M + H-H~2~O\]^+^, 130                                                                  

  **26**   43.5            *Z*-Ligustilide (190)            237, 260, 312      213             191            403              173\[M + H-H~2~O\]^+^, 145\[173-28\]^+^ 130,\                                               
                                                                                                                               117, 105                                                                                   

  **28**   44.0            3-Butylidenephthalide (188)      230, 277, 326      211             189                             171\[M + H-H~2~O\]^+^, 153\[171-H~2~O\]^+^                                                  

  **29**   47.4            Riligustilide (380)              275                403             381                             213\[2M + Na-190\]^+^, 191, 173                                                             

  **30**   47.5            Senkyunolide P (382)             278                405             383                             192\[M + H-190\]^+^                                                                         

  **31**   47.8            3′,6,8′,3a-Biligustilide (380)   278, 363           403             381                             213\[2M + Na-190\]^+^, 191\[M + H-190\]^+^,\                                                
                                                                                                                               145, 117                                                                                   

  **32**   48.0            Tokinolide B (380)               278                403             381                             213\[2M + Na-190\]^+^, 191\[M + H-190\]^+^                                                  

  **33**   48.2            Unidentified (382)               230, 279           405             383                             193\[M + H-190\]^+^                                                                         

  **34**   48.5            Levistolide A (380)              276                403             381                             213\[2M + Na-190\]^+^, 191\[M + H-190\]^+^,\                                                
                                                                                                                               145, 117                                                                                   

  **35**   48.8            Senkyunolide O (380)             278                403             381                             173\[191-H~2~O\]^+^, 191\[M + H-190\]^+^,\                                                  
                                                                                                                               145, 117                                                                                   

  **36**   49.0            Senkyunolide M (278)             279                301             279                             245\[M + Na-56\]^+^, 189, 171                                                               

  **37**   49.4            Senkyunolide Q (278)             278                301             279                             245\[M + Na-56\]^+^, 189, 171                                                               

  **38**   49.9            Unidentified (382)               225, 278           405             383                                                                                                                         
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Retention time (*t* ~*R*~) and MS data obtained by LC-DAD-ESI-IT-TOF/MS of the identified compounds in the sample of Tianshu Capsule.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Number   *t* ~*R*~/min   Identified compounds                                          Formula           Mea. mass/*m*/*z*      Calc. mass/*m*/*z*     Error/ppm   Other precursor ions      Main product ions
  -------- --------------- ------------------------------------------------------------- ----------------- ---------------------- ---------------------- ----------- ------------------------- --------------------------------------------
  **3**    7.6             5-HMF (126)                                                   C~6~H~6~O~3~      127.0384\[M + H\]^+^   127.0390\[M + H\]^+^   −4.72       149.0240\[M + Na\]^+^      

  **5**    19.8            Parishin B (728)                                              C~32~H~40~O~19~   727.2123\[M − H\]^−^   727.2091\[M − H\]^−^   4.40                                   

  **6**    21.5            Parishin C (728)                                              C~32~H~40~O~19~   727.2132\[M − H\]^−^   727.2091\[M − H\]^−^   5.64                                   

  **8**    24.5            3-Butyl-3,6,7-trihydroxy-4,5,6,7-tetrahydrophthalide (242)    C~12~H~18~O~5~    241.1090\[M − H\]^−^   241.1081\[M − H\]^−^   3.72                                  223.0885\[M -- H-H~2~O\]^−^, 197.1142,\
                                                                                                                                                                                               179.1107, 141.0930, 123.0854

                                                                                                           243.1220\[M + H\]^+^   243.1227\[M + H\]^+^   2.88        265.1060\[M + Na\]^+^      

  **9**    25.3            Ferulic acid (194)                                            C~10~H~10~O~4~    195.0649\[M + H\]^+^   195.0652\[M + H\]^+^   −1.54       217.0458\[M + Na\]^+^      

  **10**   27.0            Senkyunolide J/N (226)                                        C~12~H~18~O~4~    227.1259\[M + H\]^+^   227.1278\[M + H\]^+^   −3.37       249.1082\[M + Na\]^+^     209.1177\[M + H-H~2~O\]^+^,\
                                                                                                                                                                                               191.1026\[M + H-2H~2~O\]^+^

  **11**   30.3            4,5-Dihydro-3,1′-dihydroxy-3-butylphthalide (224)             C~12~H~16~O~4~    225.1105\[M + H\]^+^   225.1121\[M + H\]^+^   −7.11                                  

  **12**   31.6            Senkyunolide I/H (224)                                        C~12~H~16~O~4~    225.1105\[M + H\]^+^   225.1121\[M + H\]^+^   −7.11                                  

  **15**   37.8            Unidentified (316)                                            C~18~H~20~O~5~    317.1380\[M + H\]^+^   317.1384\[M + H\]^+^   −1.26       339.1210\[M + Na\]^+^     299.1378\[M + H-H~2~O\]^+^,\
                                                                                                                                                                                               271.1343\[M + H-H~2~O-28\]^+^

  **16**   37.8            4,7-Dihydroxy-3-butylidenephthalide or senkyunolide D (222)   C~12~H~14~O~4~    223.0986\[M + H\]^+^   223.0965\[M + H\]^+^   9.41        245.0774\[M + Na\]^+^      

  **17**   38.7            *Z*-6,7-Epoxyligustilide (206)                                C~12~H~14~O~3~    207.1008\[M + H\]^+^   207.1016\[M + H\]^+^   3.66        229.0824\[M + Na\]^+^     189.0856\[M + H-H~2~O\]^+^, 133.0318

  **18**   39.1            Senkyunolide K/G (208)                                        C~12~H~16~O~3~    209.1167\[M + H\]^+^   209.1172\[M + H\]^+^   −2.39       231.0974\[M + Na\]^+^     191.1091\[M + H-H~2~O\]^+^, 119.0819

  **19**   40.6            Senkyunolide F (206)                                          C~12~H~14~O~3~    207.1009\[M + H\]^+^   207.1016\[M + H\]^+^   3.38        229.0815\[M + Na\]^+^     189.0911\[M + H-H~2~O\]^+^, 161.0959

                                                                                                           205.0874\[M − H\]^−^   205.0870\[M − H\]^−^   1.95        411.1821\[2M − H\]^−^     161.0976\[M -- H-44\]^−^, 106.0421

  **20**   41.4            Senkyunolide A (192)                                          C~12~H~16~O~2~    193.1219\[M + H\]^+^   193.1223\[M + H\]^+^   −2.07       215.1027\[M + Na\]^+^,\   175.1119\[M + H-H~2~O\]^+^, 147.1155,\
                                                                                                                                                                     407.2196\[2M + Na\]^+^    105.0718

  **21**   42.1            Butylphthalide (190)                                          C~12~H~14~O~2~    191.1061\[M + H\]^+^   191.1067\[M + H\]^+^   −3.14       213.0872\[M + Na\]^+^,\   173.0989\[M + H-H~2~O\]^+^,\
                                                                                                                                                                     403.1888\[2M + Na\]^+^    145.1049\[M + H-H~2~O-28\]^+^

  **22**   42.9            Senkyunolide C (204)                                          C~12~H~12~O~3~    205.0847\[M + H\]^+^   205.0859\[M + H\]^+^   −5.85       227.0685\[M + Na\]^+^,\   187.0763\[M + H-H~2~O\]^+^,\
                                                                                                                                                                     431.1431\[2M + Na\]^+^    169.0757\[M + H-2H~2~O\]^+^,\
                                                                                                                                                                                               141.0699\[169-28\]^+^

  **23**   43.4            Senkyunolide E (204)                                          C~12~H~12~O~3~    205.0843\[M + H\]^+^   205.0859\[M + H\]^+^   −7.80       227.0663\[M + Na\]^+^      

  **24**   44.1            Cnidilide (194)                                               C~12~H~18~O~2~    195.1372\[M + H\]^+^   195.1380\[M + H\]^+^   −4.10       217.1185\[M + Na\]^+^     177.1323\[M + H-H~2~O\]^+^,\
                                                                                                                                                                                               149.1340\[M + H-H~2~O-28\]^+^

  **25**   44.1            *E*-Ligustilide (190)                                         C~12~H~14~O~2~    191.1061\[M + H\]^+^   191.1067\[M + H\]^+^   −3.14       213.0871\[M + Na\]^+^      

  **26**   45.2            *Z*-Ligustilide (190)                                         C~12~H~14~O~2~    191.1056\[M + H\]^+^   191.1067\[M + H\]^+^   −5.76       213.0859\[M + Na\]^+^,\   173.0984\[M + H-H~2~O\]^+^,\
                                                                                                                                                                     403.1901\[2M + Na\]^+^    145.0999\[M + H-H~2~O-28\]^+^, 117.0690

  **27**   45.5            Neocnidilide (194)                                            C~12~H~18~O~2~    195.1372\[M + H\]^+^   195.1380\[M + H\]^+^   −4.10       217.1179\[M + Na\]^+^     177.1323\[M + H-H~2~O\]^+^,\
                                                                                                                                                                                               149.1306\[M + H-H~2~O-28\]^+^, 121.0998

  **28**   45.8            3-Butylidenephthalide (188)                                   C~12~H~12~O~2~    189.0907\[M + H\]^+^   189.0910\[M + H\]^+^   −1.59       211.0720\[M + Na\]^+^     171.0817\[M + H-H~2~O\]^+^,\
                                                                                                                                                                                               153.0800\[M + H-H~2~O-H~2~O\]^+^,\
                                                                                                                                                                                               143.0882\[M + H-H~2~O-28\]^+^, 129.0724

  **29**   46.2            Riligustilide (380)                                           C~24~H~28~O~4~    381.2058\[M + H\]^+^   381.2060\[M + H\]^+^   −0.52       403.1872\[M + Na\]^+^,\    
                                                                                                                                                                     191.1060, 213.0875        

  **30**   48.9            Senkyunolide P (382)                                                            383.2220\[M + H\]^+^   383.2217\[M + H\]^+^               405.2031\[M + Na\]^+^     193.1212\[M/2 + H\]^+^

  **31**   49.2            3′,6,8′,3a-Biligustilide (380)                                C~24~H~28~O~4~    381.2058\[M + H\]^+^   381.2060\[M + H\]^+^   −0.52       403.1885\[M + Na\]^+^,\    
                                                                                                                                                                     191.1091                  

  **32**   49.8            Tokinolide B (380)                                            C~24~H~28~O~4~    381.2037\[M + H\]^+^   381.2060\[M + H\]^+^   −6.03       403.1878\[M + Na\]^+^,\    
                                                                                                                                                                     191.1062                  

  **33**   49.9            Unidentified (382)                                                              383.2220\[M + H\]^+^   383.2217\[M + H\]^+^               405.2040\[M + Na\]^+^     193.1214\[M/2 + H\]^+^

  **34**   50.3            Levistolide A (380)                                           C~24~H~28~O~4~    381.2064\[M + H\]^+^   381.2060\[M + H\]^+^   1.05        403.1887\[M + Na\]^+^,\    
                                                                                                                                                                     191.1054                  

  **35**   50.8            Senkyunolide O (380)                                          C~24~H~28~O~4~    381.2061\[M + H\]^+^   381.2060\[M + H\]^+^   0.26        403.1879\[M + Na\]^+^,\   191.1051\[M/2 + H\]^+^
                                                                                                                                                                     191.1057                  

  **36**   51.4            Senkyunolide M (278)                                                            279.1582\[M + H\]^+^                                      301.1402\[M + Na\]^+^,\    
                                                                                                                                                                     579.2952\[2M + Na\]^+^    

  **37**   52.0            Senkyunolide Q (278)                                                            279.1596\[M + H\]^+^                                      301.1381\[M + Na\]^+^,\    
                                                                                                                                                                     579.2952\[2M + Na\]^+^    

  **38**   52.7            Unidentified (382)                                                              383.2217\[M + H\]^+^   383.2217\[M + H\]^+^   0.00        405.2008\[M + Na\]^+^     365.2115, 347.1905, 193.1201\[M/2 + H\]^+^
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
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